Header Logo

Trofinetide for the treatment of Rett syndrome: a randomized phase 3 study.

Trofinetide for the treatment of Rett syndrome: a randomized phase 3 study. Nat Med. 2023 Jun; 29(6):1468-1475.

View in: PubMed